TRAINING OPPORTUNITY: NIH T32 Openings for Post-Doctoral Fellows at Emory University Emory Training Program in HIV Translational Research to End the Epidemic
Fellow-driven & mentor-supported HIV transla tional research fellowships starting Jan 1, 2022
Are you a PhD, MD, MD/PhD graduate with an int erest in HIV Translational Research? Are you within seven years of your terminal degree? Are y ou a U.S. Citizen or Naturalized (Green Card) U.S. Citizen? Can you devote two years to training?
All trainees must commit full-time effort to th e program and its related research activities.
Eligible Areas of HIV Research
- Laboratory-based science, vaccine, and cure research
- Patient-centered clinical research
- Public health and implementation science
Trainees will gain expertise in cross-cutting areas ofscience and translation to the Ending the HIV Epidemic Initiative
HIV T32 Program Trainees will Receive:
- Annual stipend at appropriate NIH-specifiedlevel based on years of postdoc experience
- Travel & childcare allotments; research supplies
- Tuition support for formal didactic training intranslational research (MSCR, CPTR, or selectedgraduate level courses)
- Hands-on translational research rotation
DEADLINE FOR SUBMISSION: November 30, 2021
1. Applicants should identify a potential mentor from the list below arranged by focus area. Applicants mustcontact the potential mentor to see if the mentor is accepting new fellows through the Emory HIV T32 program.Applicants should include their CV and a brief description of the area of mutual interest.
2. Potential candidates should complete an HIV T32 Interest Form to initiate discussion with the faculty ProgramDirector (PD) in the target area of interest regarding the candidate application: https://bit.ly/EmoryHIVT32
a. Laboratory-based basic science, vaccine, and cure research: Ann Chahroudi, MD, PhD
b .Patient-centered clinical research: Colleen Kelley, MD, MPH
c. Public health and implementation science: Patrick Sullivan, DVM, PhD
3. Approval to apply must be obtained prior to November 15, 2021. Candidates are encouraged to apply aftermentor and program reviews are complete and approval is given.
To apply, submit an application package including the following documents as a single PDF via email to firstname.lastname@example.org by 5 PM EST on November 30, 2021:
- Cover letter specifying focus area of interest with statement of future goals for a career in HIV research. Applicantshould include personal qualifications for the fellowship and what they hope to gain from the fellowship;
- Current CV or NIH biosketch;
- A letter of support from the proposed HIV T32 mentor;
- Letter(s) of support from one other scientist (e.g. recent supervisor, mentor, or a collaborator);
- A two-page description of the proposed research project and proposed didactic training plan (includinggraphs/figures but not references);
- MD applicants from clinical departments must also provide a letter from the applicant’s Department/DivisionChair, indicating departmental commitment to provide at least 75% protected time for the trainee applicant todevote to the proposed research project. This letter can be same as the required letter of support from one otherscientist, described above.